The underlying molecular mechanism and identification of transcription factor markers for laryngeal squamous cell carcinoma

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132.
   PubMed Web of Science ®Google Scholar
• Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62(1):10–29.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30.
   PubMed Web of Science ®Google Scholar
• Steuer CE, El-Deiry M, Parks JR, et al. An update on larynx cancer. CA Cancer J Clin. 2017;67(1):31–50.
   PubMed Web of Science ®Google Scholar
• Dietz A, Wichmann G, Kuhnt T, et al. Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy-final results of the larynx organ preservation trial DeLOS-II. Ann Oncol. 2018;29(10):2105–2114.
   PubMed Web of Science ®Google Scholar
• Wang K, Tang J, Liu X, et al. UBR5 regulates proliferation and radiosensitivity in human laryngeal carcinoma via the p38/MAPK signaling pathway. Oncol Rep. 2020;44(2):685–697.
   PubMed Web of Science ®Google Scholar
• Wang W, Sun Y, Li X, et al. Dihydroartemisinin prevents distant metastasis of laryngeal carcinoma by inactivating STAT3 in cancer stem cells. Med Sci Monit. 2020;26:e922348.
   PubMed Web of Science ®Google Scholar
• Haapaniemi A, Koivunen P, Saarilahti K, et al. Laryngeal cancer in Finland: a 5-year follow-up study of 366 patients. Head Neck. 2016;38(1):36–43.
   PubMed Web of Science ®Google Scholar
• Pedregal-Mallo D, Sanchez Canteli M, Lopez F, et al. Oncological and functional outcomes of transoral laser surgery for laryngeal carcinoma. Eur Arch Otorhinolaryngol. 2018;275(8):2071–2077.
   PubMed Web of Science ®Google Scholar
• Cetinayak O, Dogan E, Kuru A, et al. Outcome of early-stage glottic laryngeal carcinoma patients treated with radical radiotherapy using different techniques. J Oncol. 2019;2019:8640549.
   PubMed Web of Science ®Google Scholar
• Zhu X, Zhao M, Zhou L, et al. Significance of examined lymph nodes number and metastatic lymph nodes ratio in overall survival and adjuvant treatment decision in resected laryngeal carcinoma. Cancer Med. 2020;9(9):3006–3014.
   PubMed Web of Science ®Google Scholar
• Nocini R, Molteni G, Mattiuzzi C, et al. Updates on larynx cancer epidemiology. Chin J Cancer Res. 2020;32(1):18–25.
   PubMed Web of Science ®Google Scholar
• Ciolofan MS, Vlaescu AN, Mogoanta CA, et al. Clinical, histological and immunohistochemical evaluation of larynx cancer. Curr Health Sci J. 2017;43(4):367–375.
   PubMedGoogle Scholar
• Menach OP, Patel A, Oburra HO. Demography and histologic pattern of laryngeal squamous cell carcinoma in kenya. Int J Otolaryngol. 2014;2014:507189.
   PubMedGoogle Scholar
• Praud D, Rota M, Rehm J, et al. Cancer incidence and mortality attributable to alcohol consumption. Int J Cancer. 2016;138(6):1380–1387.
   PubMed Web of Science ®Google Scholar
• Kang DM, Kim JE, Kim YK, et al. Occupational burden of asbestos-related diseases in Korea, 1998-2013: asbestosis, mesothelioma, lung cancer, laryngeal cancer, and ovarian cancer. J Korean Med Sci. 2018;33(35):e226.
   PubMed Web of Science ®Google Scholar
• Yang D, Shi Y, Tang Y, et al. Effect of HPV infection on the occurrence and development of laryngeal cancer: a review. J Cancer. 2019;10(19):4455–4462.
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhang F, Niu R. Functions of Shp2 in cancer. J Cell Mol Med. 2015;19(9):2075–2083.
   PubMed Web of Science ®Google Scholar
• Lan L, Cao H, Chi W, et al. Aberrant DNA hypermethylation-silenced LINC00886 gene accelerates malignant progression of laryngeal carcinoma. Pathol Res Pract. 2020;216(4):152877.
   PubMed Web of Science ®Google Scholar
• Gu J, Han T, Ma RH, et al. SHP2 promotes laryngeal cancer growth through the Ras/Raf/Mek/Erk pathway and serves as a prognostic indicator for laryngeal cancer. Int J Oncol. 2014;44(2):481–490.
   PubMed Web of Science ®Google Scholar
• Wang S, Guo D, Li C. Downregulation of miRNA-26b inhibits cancer proliferation of laryngeal carcinoma through autophagy by targeting ULK2 and inactivation of the PTEN/AKT pathway. Oncol Rep. 2017;38(3):1679–1687.
   PubMed Web of Science ®Google Scholar
• Tian L, Tao ZZ, Ye HP, et al. Over-expression of MEOX2 promotes apoptosis through inhibiting the PI3K/Akt pathway in laryngeal cancer cells. Neoplasma. 2018;65(5):745–752.
   PubMed Web of Science ®Google Scholar
• Li L, Liang Y, Kang L, et al. Transcriptional regulation of the warburg effect in cancer by SIX1. Cancer Cell. 2018;33(3):368–85 e7.
   PubMed Web of Science ®Google Scholar
• Gao L, Hu Y, Tian Y, et al. Lung cancer deficient in the tumor suppressor GATA4 is sensitive to TGFBR1 inhibition. Nat Commun. 2019;10(1):1665.
   PubMedGoogle Scholar
• Yang N, Hui L, Wang Y, et al. Overexpression of SOX2 promotes migration, invasion, and epithelial-mesenchymal transition through the Wnt/beta-catenin pathway in laryngeal cancer Hep-2 cells. Tumour Biol. 2014;35(8):7965–7973.
   PubMedGoogle Scholar
• Feng J, Sun Q, Wu T, et al. Upregulation of ATF-3 is correlated with prognosis and proliferation of laryngeal cancer by regulating Cyclin D1 expression. Int J Clin Exp Pathol. 2013;6(10):2064–2070.
   PubMed Web of Science ®Google Scholar
• Jiang LZ, Wang P, Deng B, et al. Overexpression of Forkhead Box M1 transcription factor and nuclear factor-kappaB in laryngeal squamous cell carcinoma: a potential indicator for poor prognosis. Hum Pathol. 2011;42(8):1185–1193.
   PubMed Web of Science ®Google Scholar
• Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.
   PubMed Web of Science ®Google Scholar
• Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139–140.
   PubMed Web of Science ®Google Scholar
• Gene Ontology Consortium. Gene ontology consortium: going forward. Nucleic Acids Res. 2015;43(Databaseissue):D1049–D56.
   PubMedGoogle Scholar
• Kanehisa M, Furumichi M, Tanabe M, et al. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017;45(D1):D353–D61.
   PubMed Web of Science ®Google Scholar
• Yu G, Wang L-G, Han Y, et al. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284–287.
   PubMed Web of Science ®Google Scholar
• Walter W, Sánchez-Cabo F, Ricote M. GOplot: an R package for visually combining expression data with functional analysis. Bioinformatics. 2015;31(17):2912–2914.
   PubMed Web of Science ®Google Scholar
• Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–2504.
   PubMed Web of Science ®Google Scholar
• Wang S, Zang C, Xiao T, et al. Modeling cis-regulation with a compendium of genome-wide histone H3K27ac profiles. Genome Res. 2016;26(10):1417–1429.
   PubMed Web of Science ®Google Scholar
• Zheng R, Wan C, Mei S, et al. Cistrome data browser: expanded datasets and new tools for gene regulatory analysis. Nucleic Acids Res. 2019;47(D1):D729–D35.
   PubMed Web of Science ®Google Scholar
• Stormo GD. Modeling the specificity of protein-DNA interactions. Quant Biol. 2013;1(2):115–130.
   PubMedGoogle Scholar
• Wasserman WW, Sandelin A. Applied bioinformatics for the identification of regulatory elements. Nat Rev Genet. 2004;5(4):276–287.
   PubMed Web of Science ®Google Scholar
• Grant CE, Bailey TL, Noble WS. FIMO: scanning for occurrences of a given motif. Bioinformatics. 2011;27(7):1017–1018.
   PubMed Web of Science ®Google Scholar
• Cox OT, Edmunds SJ, Simon-Keller K, et al. PDLIM2 is a marker of adhesion and beta-catenin activity in triple-negative breast cancer. Cancer Res. 2019;79(10):2619–2633.
   PubMed Web of Science ®Google Scholar
• Xu Y, Yu W, Yang T, et al. Overexpression of BCAT1 is a prognostic marker in gastric cancer. Hum Pathol. 2018;75:41–46.
   PubMed Web of Science ®Google Scholar
• Wu CJ, Sundararajan V, Sheu BC, et al. Activation of STAT3 and STAT5 signaling in epithelial ovarian cancer progression: mechanism and therapeutic opportunity. Cancers (Basel). 2019;12(1). DOI:10.3390/cancers12010024
   Web of Science ®Google Scholar
• Sun L, Zhang L, Chen J, et al. Activation of tyrosine metabolism in CD13+ cancer stem cells drives relapse in hepatocellular carcinoma. Cancer Res Treat. 2020;52(2):604–621.
   PubMed Web of Science ®Google Scholar
• Bao Y, Wang L, Shi L, et al. Transcriptome profiling revealed multiple genes and ECM-receptor interaction pathways that may be associated with breast cancer. Cell Mol Biol Lett. 2019;24:38.
   PubMed Web of Science ®Google Scholar
• Shen J, Cao B, Wang Y, et al. Hippo component YAP promotes focal adhesion and tumour aggressiveness via transcriptionally activating THBS1/FAK signalling in breast cancer. J Exp Clin Cancer Res. 2018;37(1):175.
   PubMedGoogle Scholar
• Huang J, Li Y, Lu Z, et al. Analysis of functional hub genes identifies CDC45 as an oncogene in non-small cell lung cancer - a short report. Cell Oncol (Dordr). 2019;42(4):571–578.
   PubMed Web of Science ®Google Scholar
• Yan L, Li Q, Yang J, et al. TPX2-p53-GLIPR1 regulatory circuitry in cell proliferation, invasion, and tumor growth of bladder cancer. J Cell Biochem. 2018;119(2):1791–1803.
   PubMed Web of Science ®Google Scholar
• Wu C, Lyu J, Yang EJ, et al. Targeting AURKA-CDC25C axis to induce synthetic lethality in ARID1A-deficient colorectal cancer cells. Nat Commun. 2018;9(1):3212.
   PubMedGoogle Scholar
• Bhatia R, Gautam SK, Cannon A, et al. Cancer-associated mucins: role in immune modulation and metastasis. Cancer Metastasis Rev. 2019;38(1–2):223–236.
   PubMed Web of Science ®Google Scholar
• Zhao X, Zhang W, Ji W. miR-181a targets GATA6 to inhibit the progression of human laryngeal squamous cell carcinoma. Future Oncol. 2018;14(17):1741–1753.
   PubMed Web of Science ®Google Scholar
• Sun C, Han C, Wang P, et al. HOXB9 expression correlates with histological grade and prognosis in LSCC. Biomed Res Int. 2017;2017:3680305.
   PubMed Web of Science ®Google Scholar
• Kayisaier K, Abulajiang T, Tang L, et al. Effect of miR-340-5p on proliferation of laryngeal cancer Hep2 cells and its intrinsic molecular mechanism. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2020;34(2):140–145.
   PubMedGoogle Scholar
• Sun Z, Yan B. Multiple roles and regulatory mechanisms of the transcription factor GATA6 in human cancers. Clin Genet. 2020;97(1):64–72.
   PubMed Web of Science ®Google Scholar
• Guoping M, Ran L, Yanru Q. miR-143 inhibits cell proliferation of gastric cancer cells through targeting GATA6. Oncol Res. 2018;26(7):1023–1029.
   PubMed Web of Science ®Google Scholar
• Shen W, Niu N, Lawson B, et al. GATA6: a new predictor for prognosis in ovarian cancer. Hum Pathol. 2019;86:163–169.
   PubMed Web of Science ®Google Scholar
• Liang G, Meng W, Huang X, et al. miR-196b-5p-mediated downregulation of TSPAN12 and GATA6 promotes tumor progression in non-small cell lung cancer. Proc Natl Acad Sci U S A. 2020;117(8):4347–4357.
   PubMed Web of Science ®Google Scholar
• Yue W, Zhao R, Yu T. The expression and significance of Dickkopf-1 and GATA-6 in laryngeal carcinoma. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2014;28(9):643–646.
   PubMedGoogle Scholar
• Guo Z, Zhu H, Xu W, et al. Alternative splicing related genetic variants contribute to bladder cancer risk. Mol Carcinog. 2020;59(8):923–929.
   PubMed Web of Science ®Google Scholar
• Tsuchiya H, Oura S. Involvement of MAFB and MAFF in retinoid-mediated suppression of hepatocellular carcinoma invasion. Int J Mol Sci. 2018;19(5):1450.
   Web of Science ®Google Scholar
• Wu M, Deng X, Zhong Y, et al. MafF is regulated via the circ-ITCH/miR-224-5p axis and acts as a tumor suppressor in hepatocellular carcinoma. Oncol Res. 2020;28(3):299–309.
   PubMed Web of Science ®Google Scholar
• Bhatlekar S, Fields JZ, Boman BM. HOX genes and their role in the development of human cancers. J Mol Med (Berl). 2014;92(8):811–823.
   PubMed Web of Science ®Google Scholar
• Wang X, Sun Y, Xu T, et al. HOXB13 promotes proliferation, migration, and invasion of glioblastoma through transcriptional upregulation of lncRNA HOXC-AS3. J Cell Biochem. 2019;120(9):15527–15537.
   PubMed Web of Science ®Google Scholar
• Aspuria PJ, Cheon DJ, Gozo MC, et al. HOXB13 controls cell state through super-enhancers. Exp Cell Res. 2020;393(1):112039.
   PubMed Web of Science ®Google Scholar
• Liu B, Wang T, Wang H, et al. Oncoprotein HBXIP enhances HOXB13 acetylation and co-activates HOXB13 to confer tamoxifen resistance in breast cancer. J Hematol Oncol. 2018;11(1):26.
   PubMedGoogle Scholar
• Xie B, Bai B, Xu Y, et al. Tumor-suppressive function and mechanism of HOXB13 in right-sided colon cancer. Signal Transduct Target Ther. 2019;4:51.
   PubMed Web of Science ®Google Scholar
• Sui BQ, Zhang CD, Liu JC, et al. HOXB13 expression and promoter methylation as a candidate biomarker in gastric cancer. Oncol Lett. 2018;15(6):8833–8840.
   PubMed Web of Science ®Google Scholar